Byron Michael 4

What Happened
Byron Michael, a director of Aeluma, was granted equity awards in two transactions: 13,343 restricted stock units (RSUs) reported as an acquisition on December 3, 2025, and 3,653 RSUs reported as an earlier derivative award on September 1, 2025. Both grants are reported with an acquisition price of $0.00 (i.e., awards rather than purchases) and therefore show $0 cash paid on the Form 4; market value at vesting is separate from the filing. The September 1, 2025 award is noted as a derivative and is fully vested per the filing footnote.

Key Details

• Transaction dates and prices:
  • 2025-12-03: Grant/acquisition of 13,343 RSUs at $0.00 (Footnote F1).
  • 2025-09-01: Grant/acquisition of 3,653 RSUs (derivative) at $0.00; fully vested (Footnote F2).
• Vesting schedule (Footnote F1): the 13,343 RSUs vest ~1/12 on Dec 31, 2025; 1/4 on Mar 31, Jun 30, and Sep 30, 2026; and 1/6 on Nov 30, 2026.
• Shares owned after the transactions are not stated in the provided filing.
• Filing timing: the Form 4 was filed on Mar 2, 2026 for a Dec 3, 2025 transaction — outside the typical 2-business-day window for Form 4s, meaning the report appears to be delayed (this can affect transparency but does not change the underlying award).
• Transaction codes: A = Award/Grant; the September entry is marked as a derivative award.

Context
These entries are equity awards (RSUs), not open-market purchases or sales. RSU grants are common compensation for executives and directors; the $0 acquisition price reflects that the shares were awarded rather than bought. For the 13,343 RSUs, vesting is scheduled over late 2025–2026, so those shares will convert to actual stock only as they vest. The fully vested 3,653 RSUs likely represent immediate beneficial ownership. Awards do not by themselves indicate a buy or sell signal from the insider.